Cryogenic OGS
Q4 FY27 Earnings Call Analysis
Industrial Manufacturing
fundraise: No informationcapex: Yesrevenue: Category 2margin: Category 3orderbook: Yes
📋orderbook
Current/ Expected Orderbook/ Pending Orders?
- Current order book/post sales: Approximately ₹22 to ₹25 crore.
- Bids submitted: Around ₹65 crore as of the date.
- Expectation for the second half of FY26: Similar growth to the first half.
- Significant ongoing projects: 143 truck loading skids for Egypt and a metering skid project for Honeywell Nigeria.
- Visibility on future orders: Expecting good orders of similar size in the first half of FY27 and throughout FY27.
- Additional bids and tenders: Received many new orders for density probes and quoted for different locations under tendering.
- Target markets: Both domestic and global markets are being pursued actively.
💰fundraise
Any current/future new fundraising through debt or equity?
- Cryogenic OGS Limited is a zero-debt company and has maintained strict financial discipline and balance sheet strength for the past 4 to 5 years.
- There is no mention of any current or planned fundraising through debt or equity during the event.
- The company recently raised funds through IPO to support working capital needs for transitioning from assembler/fabricator to system integrator.
- They are planning capital expenditure for a new facility within the next 2 years but have not indicated raising fresh capital for this yet.
- Existing working capital cash on hand is sufficient for current procurement and project requirements.
- Overall, no explicit plans for new debt or equity fundraising were disclosed in this event.
🏗️capex
Any current/future capex/capital investment/strategic investment?
- The company is slowly building a new facility, anticipating a need for capex within two years.
- The new facility development has begun step by step, with early preparations already underway.
- Current capacity utilization is about 35-40%; significant capex for a new facility is expected after reaching 75 to 100 crores revenue.
- Past capex done in FY17, FY20, and FY21 improved gross margins; further expansion is planned for 2-3 years down the line.
- The management expects scope to improve gross margins through higher value addition, new product certifications, and international market expansion.
- Strategic investments target new technologies in LNG and green hydrogen product capabilities and metering technologies.
- Planning to scale from a domestic engineering base to a global, integrated, high-margin solutions platform.
📊revenue
Future growth expectations in sales/revenue/volumes?
- Expecting similar growth in the second half of FY26 as in the first half.
- Order book currently around ₹22-25 crores with ₹65 crores in bids submitted.
- Facility capacity can support up to double the current revenue without major capex. Significant capex expected only after reaching ₹75-100 crores revenue.
- Aggressively targeting domestic and global markets, including expansion into LNG and green hydrogen product capabilities.
- Anticipate repeat and new orders internationally, e.g., large orders in Egypt and Nigeria, and inquiries from Middle East customers.
- Focus on scaling from domestic engineering base to global integrated solutions platform.
- Growth driven by new technologies like the density probe with increasing orders post initial success.
- Goal to improve gross margins via margin maximization on bought-out products, new products, and international customers with better margins.
📈margin
Future growth expectations in earnings/operating earnings/profits/EPS?
- Cryogenic OGS is aggressively targeting growth over the next 2-3 years, focusing on new technologies and international markets.
- They plan to scale from a strong domestic base to a global, integrated, high-margin solutions platform.
- Expectation to maintain or improve EBITDA margins around 30% and gross margins around 20% going forward.
- Growth drivers include expansion in LNG, green hydrogen capabilities, metering technologies, and international orders.
- The company is transitioning from assembler/fabricator to full systems integrator, enabling higher value addition and better margins.
- Order book and bid pipeline remain strong with over ₹22-25 crores in confirmed orders and ₹65 crores in bids.
- Capacity utilization is at 35-40%, allowing 50-100% revenue growth without immediate major Capex.
- New facility development is underway, anticipating capacity expansion in 2-3 years to support further revenue growth.
